SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹0.58 Cr | ₹-0.09 Cr | ₹0.20 Cr | ₹0.24 Cr | ₹0.28 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SHREE GANESH REMEDIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹0.58 Cr |
Mar2023 | ₹-0.09 Cr |
Mar2022 | ₹0.20 Cr |
Mar2021 | ₹0.24 Cr |
Mar2020 | ₹0.28 Cr |
How is Deferred Tax Assets / Liabilities of SHREE GANESH REMEDIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹0.58 Cr | Positive | |
Mar2023 | ₹-0.09 Cr | Negative | |
Mar2022 | ₹0.20 Cr | -16.32 | |
Mar2021 | ₹0.24 Cr | -13.09 | |
Mar2020 | ₹0.28 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of SHREE GANESH REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHREE GANESH REMEDIES | ₹856.0 Cr | 5.4% | -8.1% | -0.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹443,661.0 Cr | -1.8% | 2.7% | 49.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,496.0 Cr | -0.2% | -3.4% | 57% | Stock Analytics | |
CIPLA | ₹121,970.0 Cr | -0.7% | 0.6% | 22.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,877.0 Cr | -1.8% | 11.3% | 18% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,163.2 Cr | 1.9% | 0.5% | 41.9% | Stock Analytics |
SHREE GANESH REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | 5.4% |
-8.1% |
-0.1% |
SENSEX | 0.7% |
-2% |
9.7% |
You may also like the below Video Courses